*Corresponding Author E-mail: vedants175@gmail.com
AI-powered systems can expedite the drug discovery process by examining vast amounts of medical data, identifying potential therapeutic targets, and forecasting the advantages of novel pharmacological approaches. Recent breakthroughs in scientific research have allowed scientists to develop medications specifically designed for certain groups of individuals. By employing computer vision, researchers can examine vast amounts of medical data, and they can identify existing drugs that may be suitable for treating specific medical conditions. AI streamlines the medical development process and lowers costs by repurposing medications that have already received approval. AI systems rely on data from early-stage and clinical trials to forecast different pharmacological attributes. They can accomplish this by utilizing artificial intelligence (AI) methods to examine vast amounts of data and pinpoint chemical markers that indicate both effectiveness and potential hazards. By integrating artificial intelligence into all aspects of their operations, pharmaceutical companies have the potential to triple their profits, surpassing their current levels. We expect that by 2030, companies will wholeheartedly adopt the emerging approach and acknowledge it as an essential component of their business strategies. As AI technology progresses, it is anticipated to result in the creation of more complex and accurate medication interactions. The collaboration between healthcare experts and researchers will propel advancements in AI technology, empowering drugstores to cater to the changing demands of their customers. The incorporation of AI in the pharmaceutical supply chain presents an opportunity to improve precision and efficiency by optimizing workflows, identifying new possibilities, and enabling employees to concentrate on more significant responsibilities. It is important to look forward to many activities. Artificial intelligence is also used in the evaluation of diseases and biomarkers. We describe different research models, general methods, and how they are used in drug research.
Bioinformatics, Surgical Robotics, Biomarkers, Artificial Intelligence, Smart Electronic Health Records